Invesco
ENTL

Invesco’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Invesco’s Portfolio ENTL Stock Details ENTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-204
Closed -$5K – 4173
2015
Q2 		$5K Buy
+204
New +$5.16K ﹤0.01% 4255

Other funds holding ENTL

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco's ENTL Position: Q3 2015 in Review

Invesco sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q3 2015, closing a stake of 204 shares — an estimated $5K sold.

Invesco first reported a position in ENTL in Q2 2015 and held it in 1 quarter. The position peaked at $5K in Q2 2015. 53 funds tracked by Wall St. Rank hold ENTL as of Q3 2015.

  • Invesco reported no remaining Entellus Medical, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Invesco sold 204 Entellus Medical, Inc. Common Stock shares in Q3 2015, an estimated $5K.
  • Invesco first reported a position in Entellus Medical, Inc. Common Stock in Q2 2015 and held it in 1 quarter.
  • Invesco's Entellus Medical, Inc. Common Stock position peaked at $5K in Q2 2015.
  • 53 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q3 2015.

Based on Invesco's 13F filing for Q3 2015, filed 16 Nov 2015.